[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') dichlorideplatinum(II)
CAS : 61848-66-6
Ref. 3D-FC71939
1mg | Arrêté | ||
2mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté |
Informations sur le produit
- trans(-)-Dichloro-1,2-diaminocyclohexaneplatinum(II)
[(SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') dichlorideplatinum(II) is a platinum based anticancer drug that is used in the treatment of cancer. It has been shown to have an antitumor effect on human ovarian carcinoma, murine leukemia and carcinoma cell lines. This compound also has synergistic effects with other drugs, such as cisplatin and carboplatin. [(SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') dichlorideplatinum(II) has been shown to be effective in the treatment of various types of cancerous tissue. The mechanism by which [(SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') dichlorideplatinum(II) exerts its cytot